Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
26 studies found for:    Open Studies | "Platelet Aggregation Inhibitors"
Show Display Options
Rank Status Study
21 Recruiting Study Comparing Ticagrelor With Aspirin for Prevention of Vascular Events in Patients Undergoing CABG
Conditions: Coronary Artery Disease;   Stable Angina;   Acute Coronary Syndrome
Interventions: Drug: Ticagrelor;   Drug: Aspirin;   Drug: Placebo - Ticagrelor;   Drug: Placebo - Aspirin
22 Recruiting ASpirin vs Triflusal for Event Reduction In Atherothrombosis Secondary Prevention (ASTERIAS)
Condition: Atherothrombosis
Interventions: Drug: Aspirin;   Drug: Triflusal
23 Recruiting Sexual Hormones and Haemostasis: Observations for Women Health
Conditions: Gender;   Sex
Intervention:
24 Recruiting Is Efficacy of PLAtelet Aggregation Inhibition by Ticagrelor Mediated P2Y12 Blockade Dependent Upon Endogenous Endothelial Nitric OXide?
Condition: Acute Coronary Syndome
Interventions: Other: Blood Test;   Other: EndoPAT - endothelial assessment
25 Recruiting What is the Optimal antiplatElet and Anticoagulant Therapy in Patients With Oral Anticoagulation Undergoing revasculariSaTion 2.
Conditions: Atrial Fibrillations;   Heart Valve Prostheses;   Acute Coronary Syndromes;   Coronary Artery Diseases;   Stroke;   Bleeding;   Myocardial Infarction
Intervention: Drug: Combination of chronic oral anticoagulation and a P2Y12 inhibitor with or without aspirin.
26 Recruiting Resveratrol and First-degree Relatives of Type 2 Diabetic Patients
Condition: Pre-diabetes
Interventions: Dietary Supplement: placebo;   Dietary Supplement: resveratrol

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-26) Next Page   
Study has passed its completion date and status has not been verified in more than two years.